Beacon Biosignals co-founder and CEO Jacob Donoghue on bringing precision medicine to neurology, using EEG and machine learning to pick the right therapy for the right brain.

A look at Google’s Med-PaLM 2 and what large language models mean for medicine, from search and software to the prospect of a chatbot as a first point of clinical contact.

Inscripta’s team on the bioeconomy: engineering yeast and bacteria in fermentation tanks to produce medicines, agricultural products and cosmetics at industrial scale.

1910 Genetics founder and CEO Jen Nwankwo on where machine learning genuinely speeds up drug discovery, from target identification through preclinical testing, and how startup funding has shifted.

Cry Me a Biomarker: Using Tears to Screen for Cancer…